Home LiteratureArticle Details
PMID: 12576324 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras and junD.

Blood ·Vol. 101 ·No. 10 ·2003-05-15 ·Pages 4033-41

Nicolaou F, Teodoridis JM, Park H, Georgakis A, Farokhzad OC, Böttinger EP, Da Silva N, Rousselot P, Chomienne C, Ferenczi K, Arnaout MA, Shelley CS

Abstract

Hairy cell leukemia (HCL) is a chronic lymphoproliferative disease, the cause of which is unknown. Diagnostic of HCL is abnormal expression of the gene that encodes the beta2 integrin CD11c. In order to determine the cause of CD11c gene expression in HCL the CD11c gene promoter was characterized. Transfection of the CD11c promoter linked to a luciferase reporter gene indicated that it is sufficient to direct expression in hairy cells. Mutation analysis demonstrated that of predominant importance to the activity of the CD11c promoter is its interaction with the activator protein-1 (AP-1) family of transcription factors. Comparison of nuclear extracts prepared from hairy cells with those prepared from other cell types indicated that hairy cells exhibit abnormal constitutive expression of an AP-1 complex containing JunD. Functional inhibition of AP-1 expressed by hairy cells reduced CD11c promoter activity by 80%. Inhibition of Ras, which represents an upstream activator of AP-1, also significantly inhibited the CD11c promoter. Furthermore, in the hairy cell line EH, inhibition of Ras signaling through mitogen-activated protein kinase/extracellular signal-regulated kinase kinases 1 and 2 (MEK1/2) reduced not only CD11c promoter activity but also reduced both CD11c surface expression and proliferation. Expression in nonhairy cells of a dominant-positive Ras mutant activated the CD11c promoter to levels equivalent to those in hairy cells. Together, these data indicate that the abnormal expression of the CD11c gene characteristic of HCL is dependent upon activation of the proto-oncogenes ras and junD.

MeSH Terms
Antigens, CD/genetics Base Sequence Binding Sites Butadienes/pharmacology CD11c Antigen/genetics Cell Division/drug effects Enzyme Inhibitors/pharmacology Gene Expression Regulation, Neoplastic Genes, jun Genes, ras HeLa Cells Humans Leukemia, Hairy Cell/genetics,immunology,pathology Molecular Sequence Data Nitriles/pharmacology Plasmids Promoter Regions, Genetic Proto-Oncogenes Transcription Factor AP-1/metabolism Tumor Cells, Cultured U937 Cells
Chemicals
Antigens, CD Butadienes CD11c Antigen Enzyme Inhibitors Nitriles Transcription Factor AP-1 U 0126
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Nicolaou Fotini
Renal Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.
Teodoridis Jens M
Park Heiyoung
Georgakis Alexander
Farokhzad Omid C
Böttinger Erwin P
Da Silva Nicolas
Rousselot Philippe
Chomienne Christine
Ferenczi Katalin
Arnaout M Amin
Shelley C Simon
Article Info
Journal
Blood
Abbr.
Blood
ISSN
0006-4971
Published
2003-05-15
Epub
2003-00-06
Pages
4033-41
Language
English
Region
United States
NLM ID
7603509
Subset
IM
Grants
NIDDK NIH HHS · DK43351 · United States
NIDDK NIH HHS · DK50305 · United States
NIDDK NIH HHS · DK50779 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com